fluoxetine 25 MG (as fluoxetine hydrochloride) / olanzapine 3 MG Oral Capsule
- RxCUI
- 721787
- RxNorm name
- fluoxetine 25 MG (as fluoxetine hydrochloride) / olanzapine 3 MG Oral Capsule
- Display name
- fluoxetine 25 MG (as fluoxetine hydrochloride) / olanzapine 3 MG Oral Capsule
- Full name
- fluoxetine 25 MG (as fluoxetine hydrochloride) / olanzapine 3 MG Oral Capsule
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:54
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olanzapine and Fluoxetine | OLANZAPINE AND FLUOXETINE | Teva Pharmaceuticals USA, Inc. | 3c28cf18-01a3-468a-ab3e-8aa82f918251 | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | 721787 |
| Olanzapine and Fluoxetine | OLANZAPINE AND FUOXETINE | Par Health USA, LLC | 2f6ceda3-3edc-4427-98a6-23e3c930c44d | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | 721787 |
| Olanzapine and Fluoxetine | OLANZAPINE AND FLUOXETINE | AvKARE | f5f78ed2-4640-8528-c51c-d7bffa045d48 | 2025-10-15 | Boxed warning, Warnings, Adverse reactions | 721787 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3c28cf18-01a3-468a-ab3e-8aa82f918251 | OLANZapine 3 MG / FLUoxetine HCl 25 MG Oral Capsule [PSN] · fluoxetine 25 MG / olanzapine 3 MG Oral Capsule [SCD] · fluoxetine 25 MG (as fluoxetine hydrochloride) / olanzapine 3 MG Oral Capsule [SY] | 3 | 28 | These highlights do not include all the information needed to use OLANZAPINE AND FLUOXETINE CAPSULES safely and effectively. See full prescribing information for OLANZAPINE AND FLUOXETINE CAPSULES. OLANZAPINE and FLUOXETINE capsules, for oral use Initial U.S. Approval: 2003 | 20260331 |
| 2f6ceda3-3edc-4427-98a6-23e3c930c44d | OLANZapine 3 MG / FLUoxetine HCl 25 MG Oral Capsule [PSN] · fluoxetine 25 MG / olanzapine 3 MG Oral Capsule [SCD] · fluoxetine 25 MG (as fluoxetine hydrochloride) / olanzapine 3 MG Oral Capsule [SY] | 3 | 22 | These highlights do not include all the information needed to use OLANZAPINE AND FLUOXETINE CAPSULES safely and effectively. See full prescribing information for OLANZAPINE AND FLUOXETINE CAPSULES. OLANZAPINE and FLUOXETINE capsules, for oral use Initial U.S. Approval: 2003 | 20260331 |
| f5f78ed2-4640-8528-c51c-d7bffa045d48 | OLANZapine 3 MG / FLUoxetine HCl 25 MG Oral Capsule [PSN] · fluoxetine 25 MG / olanzapine 3 MG Oral Capsule [SCD] · fluoxetine 25 MG (as fluoxetine hydrochloride) / olanzapine 3 MG Oral Capsule [SY] | 3 | 8 | Olanzapine and Fluoxetine Capsules USP Rx Only These highlights do not include all the information needed to use OLANZAPINE AND FLUOXETINE CAPSULES safely and effectively. See full prescribing information for OLANZAPINE AND FLUOXETINE CAPSULES. OLANZAPINE and FLUOXETINE capsules, for oral use Initial U.S. Approval: 2003 | 20251015 |